Hendrika C A M Hazendonk

6PUBLICATIONS
4CO-AUTHORS
HaematologyComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 06, 2019
Current dosing practices for perioperative factor VIII concentrate treatment in mild haemophilia A patients result in FVIII levels above target.

Lisette M Schütte, Nils de Rooij, Hendrika C A M Hazendonk

|Nov 06, 2018
Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery.

T Preijers, H C A M Hazendonk, R Liesner

|May 01, 2018
Perioperative replacement therapy in haemophilia B: An appeal to "B" more precise.

H C A M Hazendonk, T Preijers, R Liesner

|Jul 09, 2017
In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients.

T Preijers, H C A M Hazendonk, K Fijnvandraat

|Sep 24, 2016
Pharmacokinetic-guided dosing of factor VIII concentrate in a patient with haemophilia during renal transplantation.

Hendrika C A M Hazendonk, Marieke J H A Kruip, Ron A A Mathôt

|Dec 30, 2015
Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications.

H C A M Hazendonk, J Lock, R A A Mathôt

Pageof 1

Frequent Collaborators

2 joint publications

T Preijers

2 joint publications

Frank W G Leebeek

1 joint publications

P Chowdary

1 joint publications

Lisette M Schütte